Task: Answer the multiple-choice question.
Query: Which drug exhibits a 17.228\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) CCOC(=O)C1(C)/C(=N/Nc2ccccc2)C(=O)C(=O)N1c1ccccc1
b.) Cc1ccc(N=Cc2cc(Cl)cc(Cl)c2O)nc1
c.) Cn1cnc([N+](=O)[O-])c1Sc1nnc(-c2cccnc2)n1C
d.) Cc1cc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)c3ccc(Cl)cc3Cl)cc2)no1
e.) CN(Cc1ccccc1F)C(=O)CNC(=O)Cc1cccc2ccccc12
Answer: c. Cn1cnc([N+](=O)[O-])c1Sc1nnc(-c2cccnc2)n1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1cnc([N+](=O)[O-])c1Sc1nnc(-c2cccnc2)n1C
Cn1cnc([N+](=O)[O-])c1Sc1nnc(-c2cccnc2)n1C
3-[4-methyl-5-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-1,2,4-triazol-3-yl]pyridine